Mycophenolate methyl ester (MME), with the CAS number 24243-40-1, is an ester derivative of mycophenolic acid, which is primarily known for its immunosuppressive properties. MME is characterized by its role as a prodrug, which is converted in the body to mycophenolic acid, the active form that inhibits lymphocyte proliferation by blocking the enzyme inosine monophosphate dehydrogenase (IMPDH). This action is crucial in preventing organ rejection in transplant patients. MME is typically a white to off-white crystalline powder, soluble in organic solvents but less so in water, reflecting its lipophilic nature. Its molecular structure includes a methyl ester functional group, contributing to its pharmacokinetic properties. MME is often administered orally and is associated with various side effects, including gastrointestinal disturbances and potential impacts on blood cell counts. Due to its immunosuppressive effects, careful monitoring is required during treatment to mitigate risks of infections and malignancies. Overall, MME is an important compound in the field of transplant medicine and autoimmune disease management.

MYCOPHENOLATE METHYL ESTER

24243-40-1: Mycophenolate methyl ester (MME), with the CAS number 24243-40-1, is an ester derivative of mycophenolic acid, which is primarily known for its immunosuppressive properties. MME is characterized by its role as a prodrug, which is converted in the body to mycophenolic acid, the active form that inhibits lymphocyte proliferation by blocking the enzyme inosine monophosphate dehydrogenase (IMPDH). This action is crucial in preventing organ rejection in transplant patients. MME is typically a white to off-white crystalline powder, soluble in organic solvents but less so in water, reflecting its lipophilic nature. Its molecular structure includes a methyl ester functional group, contributing to its pharmacokinetic properties. MME is often administered orally and is associated with various side effects, including gastrointestinal disturbances and potential impacts on blood cell counts. Due to its immunosuppressive effects, careful monitoring is required during treatment to mitigate risks of infections and malignancies. Overall, MME is an important compound in the field of transplant medicine and autoimmune disease management.

Methyl mycophenolate, a racemic mix of (E/Z) isomers, forms mycophenolic acid glucuronide and glycosides.

CAS 24243-40-1

MYCOPHENOLATE METHYL ESTER

(E/Z)-Methyl mycophenolate

Ref: TM-T19303